Appropriate selection for omalizumab treatment in patients with severe asthma?
Background: Omalizumab improves asthma control in patients with uncontrolled severe allergic asthma; however, appropriate patient selection is crucial. Information in this field is sparse. Objective: We aimed to estimate whether potential omalizumab candidates were appropriately selected according t...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2017-01-01
|
| Series: | European Clinical Respiratory Journal |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/20018525.2017.1359477 |